Tranilast

Tags: Drug.

Tranilast (INN brand name Rizaben) is an antiallergic drug. It was developed by Kissei Pharmaceuticals and was approved in 1982 for use in Japan and South Korea for bronchial asthma. Indications for keloid and hypertrophic scar were added in 1993.

thumbnail

ATC prefix

none

CAS number

53902-12-8

ChEBI

77572

FDA UNII code

HVF50SMY6E

IUPAC name

2-[(2E)-3-(34-dimethoxyphenyl)prop-2- enoyl]aminobenzoic acid

PubChem

5282230